Behavioral and psychological symptoms of dementia and bipolar spectrum disorders: Review of the evidence of a relationship and treatment implications

CNS Spectrums

Volumn 13, Issue 9, 2008, Pages 796-803

  Dorey, Jean Michel ^a,d,f   Beauchet, Olivier ^b   Anterion, Catherine Thomas ^a   Rouch, Isabelle ^a   Krolak Salmon, Pierre ^c   Gaucher, Jacques ^d   Gonthier, Régis ^a,d   Akiskal, Hagop S ^e  

^a UNIVERSITÉ JEAN MONNET   (France)

^b Angers University Hospital   (France)

^c UNIVERSITÉ LYON 1   (France)

^d UNIVERSITÉ DE LYON   (France)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITÉ LUMIÈRE LYON 2   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CHOLINESTERASE INHIBITOR; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; PLACEBO; PSYCHOTROPIC AGENT; VALPROIC ACID;

ANXIETY DISORDER; BEHAVIOR DISORDER; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BIPOLAR MANIA; CAREGIVER BURDEN; CLINICAL FEATURE; CLINICAL PRACTICE; COGNITIVE DEFECT; COMORBIDITY; CYCLOTHYMIA; DEMENTIA; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; DROWSINESS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; FAMILY HISTORY; GENETIC RISK; GERIATRICS; HUMAN; HYPOMANIA; INSTITUTIONAL CARE; LOW DRUG DOSE; MAJOR DEPRESSION; MEMORY DISORDER; MENTAL DISEASE; MONOTHERAPY; NEUROPSYCHOLOGICAL TEST; NEUROTOXICITY; OBSESSIVE COMPULSIVE DISORDER; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; PSYCHOSOCIAL CARE; PSYCHOSOCIAL DISORDER; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEDATION; SIDE EFFECT; SOMNOLENCE; SUBSTANCE ABUSE; SUICIDE ATTEMPT; SYMPTOM; TEMPERAMENT; TREMOR; WEIGHT GAIN;

EID: 54349122524     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900013924     Document Type: Review

References (53)

1. Lyketsos CG, Steinberg M, Tschanz JT, et al. Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am J Psychiatry. 2000;157:708-714.
2. Steinberg M, Sheppard JM, Tschanz JT, et al. The incidence of mental and behavioural disturbances is dementia: the cache county study. J Neuropsychiatry Clin Neurosci. 2003;15:340-345.
3. Zuidema S, Koopmans R, Verhey F. Prevalence and predictors of neuropsychiatric symptoms in cognitively impaired nursing home patients. J Geriatr Psychiatry Neurol. 2007;20:41-49.
4. Finkel SI, Costa e Silva J, Cohen G, et al. Behavioral and psychological signs of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr. 1996;8:497-500.
5. Steele C, Rovner B, Chase GA, Folstein M. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am J Psychiatry. 1990;147:1049-1051.
6. Clyburn LD, Stones MJ, Hadjistavropoulos T, Tukko H. Predicting caregiver burden and depression in Alzheimer's disease. J Gerontol B Psychol Sci Soc Sci. 2000;55:S2-S13.
7. Mittelman MS, Haley WE, Clay OJ, Roth DL. Improving caregiver well-being delays nursing home placement of patients with Alzheimer disease. Neurology. 2006;67:1592-1599.
8. Sink MS, Hodden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia. A review of the evidence. JAMA. 2005;293:596-608.
9. Dunner DL, Gershon ES, Goodwin FK. Heritable factor and the severity of the affective illness. Biol Psychiatry. 1976;11:31-42.
10. Akiskal HS, Djenderedjian AH, Rosenthal RH, Khani MK. Cyclothymic disorder: Validating criteria for inclusion in the bipolar affective group. Am J Psychiatry. 1977;134:1227-1233.
11. Klerman GL. The spectrum of mania. Compr Psychiaty. 1981;22:11-20.
12. Akiskal HS, Mallya G. Criteria for the "soft" bipolar spectrum: treatment implications. Psychopharmacol. 1987;23:68-73.
13. Akiskal HS, Pinto O. The evolving bipolar spectrum: prototypes I, II, II, and IV. Psychiatry Clin North Am. 1999;22:517-534.
14. Akiskal HS, Bourgeois ML, Angst J, et al. Re-evaluating the prevalence and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord. 2000;59:S5-S30. 15 Akiskal HS, Hantouche EG, Allilaire JF, et al. Validating antidepressant-associated hypomania (bipolar III): a systematic comparison with spontaneous hypomania (bipolar II). J Affect Disord. 2003;73:65-74.
15. Regier DA, Myers JK, Kramer M, et al. The NIMH Epidemiologic Catchment Area (ECA) Program: Historical context, major objectives and study population characteristics. Arch Gen Psychiatry. 1984;41:934-941.
16. Kessler RC, Mc Gonagle KA, Zhao S, et al. Life-time and 12 month prevalence of DSM-II-R psychiatric disorders in the United states: results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8-19.
17. Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord. 1998;50:143-151.
18. Judd LL, Akiskal HS. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord. 2003;73:123-131.
19. Merikangas KR, Simon GE, Wang, PS. Prevalence and effects of mood disorders on worK performance in a nationally representative sample of US workers. Am J Psychiatry. 2006;163:1561-1568.
20. Gorwood P. Confusing clinical presentations and differential diagnosis of bipolar disorder. Encephale. 2004;30182-193.
21. Akiskal HS, Benazzi F. Optimizing the detection of bipolar II in outpatient private practice: Toward a systematization of clinical diagnostic wisdom. J Clin Psychiatry. 2005;66:914-921.
22. Akiskal HS. Delineating irritable-choleric and hyperthymic temperaments as variants of cyclothymia. J Person Disord. 1992;6:326-342.
23. Hantouche EG, Akiskal HS, Lancrenon S, et al. Systematic clinical methodology for validating bipolar-II disorder: data in mid stream from a French national multi-site study (EPIDEP). J Affect Disord. 1998;50:163-173.
24. Allilaire JF, Hantouche EG, Sechter D, et al. Frequency and clinical aspect of BP-II: data from the French multisite study EDIDEP. Encephale. 2001;27:149-158.
25. Akiskal HS, Akiskal KK, Lancrenon S, et al. Validating the bipolar spectrum in the French National EPIDEP Study: Overview of the phenomenology and relative prevalence of its clinical prototypes. J Affect Disord. 2006;96:197-205. 27 Akiskal HS. Demystifying borderline personality: critique of the concept and unorthodox reflections on its natural kinship with the bipolar spectrum. Acta Psychiatr Scand. 2004;110:401-407.
26. Akiskal HS, Chen S, David G, et al. Borderline: an adjective in search of a noun. J Clin Psychiatry. 1985;46:41-48.
27. Perugi G, Akiskal HS, Toni C, Simonini E, Gemignani A. The temporal relationship between anxiety disorders and (hypo)mania: a retrospective examination of 63 panic, social phobic and obsessive compulsive patients with comorbid mood disorder. J Affect Disord. 2001;67:199-206.
28. The ICD-10 classification of mental and behavioral disorders. Geneva Switzerland: World Health Organization; 1992.
29. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. text rev. Washington, DC: American Psychiatric Association; 2000.
30. Akiskal HS, Placidi GF, Signoretta S, et al. TEMPS-I: Delineating the most discriminant traits of cyclothymic, depressive, irritable and hyperthymic temperaments in a non patient population. J Affect Disord. 1998;51:7-19.
31. Akiskal HS, Akiskal KK. Special Issue: TEMPS: Temperament Evaluation of Memphis, Pisa, Paris and San Diego. J Affect Disord. 2005; 85:1-242.
32. Helmer C, Peres K, Letenneur L et al. Dementia in subjects aged 75 years or over within the PAQUID cohort: prevalence and burden by severity. Dement Geriatr Cogn Disord. 2006;22:87-94.
33. Benoit M, Brocker P, Clement JP, et al. Behavioral and psychological symptoms in dementia: description and management. Rev Neurol. 2005;161:357-366.
34. Benoit M, Staccini P, Brocker P, et al. Behavioural and psychologic symptoms in Alzheimer's disease: results of the REALFR study. Rev Med Interne. 2003;24:319s-324s.
35. Stern Y, Tang MX, Albert MS, et al. Predicting time to nursing home care and death in individuals with Alzheimer disease. JAMA. 1997;277:806-812.
36. Gonzalez-Salvador MT, Arango C, Lyketsos CG, Barba AC. The stress and psychological morbidity of the Alzheimer patient caregiver. Int J Geriatr Psychiatry. 1999;14:701-710.
37. Bird M, Jones RH, Korten A, Smithers H. A controlled trial of a predominantly psychosocial approach to BPSD: treating causality, Int Psychogeriatr. 2007;19:1-20.
38. Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev. 2006;25:CD005593.
39. Gauthier S, Wirth Y, Mobius HJ. Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies. Int J Geriatr Psychiatry. 2005;10:459-464.
40. Schneider LS, Tariot PN, Dagerman KS, et al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med. 2006;335:1525-1538.
41. Galland F, Vaille-Perret E, Jalenques I. Bipolar disorders in the elderly. Psychol Neuropsychiatr Vieil. 2005;3:115-123.
42. Akiskal HS, Pinto O, Lara DR. Bipolarity in the setting of dementia: bipolar type VI? Medscape Family Medicine/Primary Care. Available at: http://www.medscape.com/viewarticle/495795. Accessed August 21, 2008.
43. Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308-2314.
44. Depp CA, Jeste DV. Bipolar disorder in older adults: a critical review. Bipolar Disorder. 2004;6:343-367.
45. Sajatovic S. Treatment of bipolar disorder in older adults. Int J Geriatr Psychiatry. 2002;17:865-873.
46. Evans DL, Byerly MY, Greer RA. Secondary mania: diagnosis and treatment. J Clin Psychiatry. 1995;56:31-37.
47. Goldberg JF. Treatment guidelines: current and future management of bipolar disorder. J Clin Psychiatry. 2000;61:12-18.
48. Meinhold JM, Blake LM, Mini LJ, et al. Effect of divalproex sodium on behavioural and cognitive problems in elderly dementia. Drugs Aging. 2005;22:615-626.
49. Tariot PN, Schneider LS, Mintzer J, et al. Safety and tolerability of divalproex sodium in the treatment of signs and symptoms of mania in elderly patients with dementia: results of a double blind controlled trial. Curr Ther Res Clin Exp. 2001;62:51-67. 52 Porsteinsson AP, Tariot PN, Erb R, et al. Placebo-controlled study of divalproex sodiom for agitation in dementia. Am J Geriatr Psychiatry. 2001;9:58-66.
50. Sival RC, Haffmans PM, Jansen PA, Duursma SA, Eikelboom P. Sodium valproate in the treatment of aggressive behavior in patients with dementia: a randomized placebo controlled clinical trial. Int J Geriatr Psychiatry. 2002;17:865-873.
51. Tariot PN, Raman R, Jakimovich L. Divalproex sodium in nursing home residents with possible or probable Alzheimer disease complicated by agitation: a randomized, controlled trial. Am J Geriatr Psychiatry. 2005;13:942-949
52. Lonergan ET, Cameron M, Luxenberg J. Valproic acid for agitation in dementia. Cochrane Database Syst Rev. 2004;2:CD003945.
53. Ng B, Camacho A, Lara DR, et al. A case series on the hypothesized connection between dementia and bipolar spectrum disorders: Bipolar type VI? J Affect Disord. 2008;107:307-315.